Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2018

01-07-2018 | Correspondence

First Observation of Hb Lepore Hollandia in the Baiga Tribal Family

Authors: Harsha Lad, Manju Yadav, Pallavi Mehta, Purushottam Patel, Pratibha Sawant, Roshan B. Colah, Malay B. Mukherjee, Rajasubramaniam Shanmugam

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2018

Login to get access

Excerpt

Hemoglobin Lepore (Hb Lepore) is an uncommon hemoglobinopathy with δβ hybrid chains produced by 7.4 kb deletion in the β-globin gene cluster. The fusion gene results in poor of synthesis of δβ hybrid chains resulting in heterozygous β-thalassemia phenotype with mild hypochromic microcytic anemia. Homozygosity for Hb Lepore or compound heterozygosity for β-thalassemia and Hb Lepore results in the phenotype of thalassemia major or thalassemia intermedia [13]. Five variants of Hb Lepore have been identified, each characterized by different gene deletion breakpoints. Hb Lepore-Boston-Washington (Hb LBW), (HGVS: NG_000007.3: g.63632_71046del) is the most commonly reported variant, worldwide and in many ethnic groups from Mediterranean countries. Hb Lepore-Baltimore, (HGVS: NG_000007.3: g.63564_70978,) is reported from Southern Europe and Latin America [46]. Hb Lepore Hollandia (HGVS: NG_000007.3: g.63290_70702del) is mainly found among individuals of Southern and Southeast Asian origin [7, 8]. Here we report the presence of Hb Lepore (δ22/β50) for the first time in a family belonging to the Baiga tribe from Dindori District, Madhya Pradesh, India. …
Literature
1.
go back to reference Bozkurt G, Baysal E, Gu L-H, Huisman THJ (1994) Thalassemia intermedia in two patients with Hb Lepore-β0-thalassemia (Frameshift codon 8,-AA). Hemoglobin 18(3):247–250CrossRefPubMed Bozkurt G, Baysal E, Gu L-H, Huisman THJ (1994) Thalassemia intermedia in two patients with Hb Lepore-β0-thalassemia (Frameshift codon 8,-AA). Hemoglobin 18(3):247–250CrossRefPubMed
2.
go back to reference Chakova L, Spasova M, Genev E (1998) Thalassemia intermedia in an infant. Folia Med 40(1):84–87 Chakova L, Spasova M, Genev E (1998) Thalassemia intermedia in an infant. Folia Med 40(1):84–87
3.
go back to reference Sreedharanunni S, Chhabra S, Kaur JH, Bansal D, Sharma P, Das R (2015) β-thalassemia intermedia caused by compound heterozygosity for Hb Lepore-Hollandia and β-thalassemia is rare in the Indian Population. Hemoglobin 39(5):362–365PubMed Sreedharanunni S, Chhabra S, Kaur JH, Bansal D, Sharma P, Das R (2015) β-thalassemia intermedia caused by compound heterozygosity for Hb Lepore-Hollandia and β-thalassemia is rare in the Indian Population. Hemoglobin 39(5):362–365PubMed
4.
go back to reference Labie D, Schroeder WA, Huisman THJ (1966) The amino acid sequence of the δ-β chains of Hemoglobin Lepore-Augusta = Lepore Washington. Biochim Biophys Acta 127(2):428–437CrossRefPubMed Labie D, Schroeder WA, Huisman THJ (1966) The amino acid sequence of the δ-β chains of Hemoglobin Lepore-Augusta = Lepore Washington. Biochim Biophys Acta 127(2):428–437CrossRefPubMed
5.
go back to reference Ostertag W, Smith EW (1969) Hemoglobin-Lepore-Baltimore, a third type of a δβ crossover (δ50, β86). Eur J Biochem 10(2):371–376CrossRefPubMed Ostertag W, Smith EW (1969) Hemoglobin-Lepore-Baltimore, a third type of a δβ crossover (δ50, β86). Eur J Biochem 10(2):371–376CrossRefPubMed
6.
go back to reference Ribeiro ML, Cunha E, Gonçalves P et al (1997) Hb Lepore-Baltimore (δ68Leu-β84Thr) and Hb Lepore-Washington-Boston (δ87Gln-βIVS-II-8) in central Portugal and Spanish Alta Extremadura. Hum Genet 99(5):669–673CrossRefPubMed Ribeiro ML, Cunha E, Gonçalves P et al (1997) Hb Lepore-Baltimore (δ68Leu-β84Thr) and Hb Lepore-Washington-Boston (δ87GlnIVS-II-8) in central Portugal and Spanish Alta Extremadura. Hum Genet 99(5):669–673CrossRefPubMed
7.
go back to reference Barnabas J, Muller CJ (1962) Hemoglobin-Lepore Hollandia. Nature 194:931–932CrossRef Barnabas J, Muller CJ (1962) Hemoglobin-Lepore Hollandia. Nature 194:931–932CrossRef
8.
go back to reference Viprakasit V, Pung-Amritt P, Suwanthon L et al (2002) Complex interactions of db hybrid hemoglobin (Hb Lepore-Hollandia) Hb E (β26(G→A)) and α+ thalassemia in a Thai family. Eur J Hematol 68(2):107–111CrossRef Viprakasit V, Pung-Amritt P, Suwanthon L et al (2002) Complex interactions of db hybrid hemoglobin (Hb Lepore-Hollandia) Hb E (β26(G→A)) and α+ thalassemia in a Thai family. Eur J Hematol 68(2):107–111CrossRef
9.
go back to reference Ghosh K, Colah RB, Mukherjee MB (2015) Haemoglobinopathies in tribal populations of India. Indian J Med Res 141(5):505–508PubMedPubMedCentral Ghosh K, Colah RB, Mukherjee MB (2015) Haemoglobinopathies in tribal populations of India. Indian J Med Res 141(5):505–508PubMedPubMedCentral
10.
go back to reference Chouhan D, Sharma R, Valki B, Parekh J (1971) Hemoglobin Lepore in an Indian Family. J Indian Med Assoc 56:287–290PubMed Chouhan D, Sharma R, Valki B, Parekh J (1971) Hemoglobin Lepore in an Indian Family. J Indian Med Assoc 56:287–290PubMed
11.
go back to reference Ropero P, Gonzalez FA, Sanchez J, Anguita E, Asenjo S, Del Acro A, Murga MJ, Ramos R, Fernandez C, Villegas A (1999) Identification of Hb Lepore phenotype by HPLC. Haematologica 84:1081–1084PubMed Ropero P, Gonzalez FA, Sanchez J, Anguita E, Asenjo S, Del Acro A, Murga MJ, Ramos R, Fernandez C, Villegas A (1999) Identification of Hb Lepore phenotype by HPLC. Haematologica 84:1081–1084PubMed
Metadata
Title
First Observation of Hb Lepore Hollandia in the Baiga Tribal Family
Authors
Harsha Lad
Manju Yadav
Pallavi Mehta
Purushottam Patel
Pratibha Sawant
Roshan B. Colah
Malay B. Mukherjee
Rajasubramaniam Shanmugam
Publication date
01-07-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0931-3

Other articles of this Issue 3/2018

Indian Journal of Hematology and Blood Transfusion 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine